AS
Amit Shantilal Jain
About Amit Shantilal Jain
Data last updated:
Amit Shantilal Jain is a Director at Ripharma Laboratories Limited (since 2015). The company operates in Pharma. Ripharma Laboratories Limited reported revenue of ₹68.14 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ripharma Laboratories Limited U24100MH2015PLC262970 | Director | 25 Mar 2015 | 2015 | ₹68.14 Cr (FY 2025) | Active |
Board colleagues of Amit Shantilal Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Milan Champalal Jain | 06388938 | Ripharma Laboratories Limited | Director |
| Rishabh Shreepal Jain | 06976344 | Ripharma Laboratories Limited | Director |
| Shantilal Rajmal Jain | 00457742 | Ripharma Laboratories Limited | Director |
| Shreepal Champalal Jain | 00457749 | Ripharma Laboratories Limited | Director |
| Shrenik Champalal Jain | 00457755 | Ripharma Laboratories Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amit Shantilal Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amit Shantilal Jain
Amit Shantilal Jain currently holds 1 directorship: Ripharma Laboratories Limited (Director, since 25 Mar 2015, revenue ₹68.14 Cr (FY 2025)).
Amit Shantilal Jain was first appointed on 25 Mar 2015 as Director at Ripharma Laboratories Limited.
The current boards of Amit Shantilal Jain's companies include Milan Champalal Jain (Ripharma Laboratories Limited), Rishabh Shreepal Jain (Ripharma Laboratories Limited), Shantilal Rajmal Jain (Ripharma Laboratories Limited), Shreepal Champalal Jain (Ripharma Laboratories Limited), Shrenik Champalal Jain (Ripharma Laboratories Limited).